永勝醫療(01612.HK)行政總裁變動
永勝醫療(01612.HK)公佈,由於要專注其他業務及個人事務,陶基祥已辭任公司執行董事及行政總裁等職務,蔡章泰將獲委任爲執行董事及行政總裁,自2023年1月1日起生效。
蔡章泰爲公司執行董事、董事會主席兼控股股東蔡文成的兒子;及公司控股股東廖佩青(爲蔡文成之配偶)的兒子。
目前蔡章泰於公司920萬股普通股中擁有權益,佔已發行股本總額1.41%,並於根據公司購股權計劃授出合共200萬份購股權中擁有權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.